European Respiratory Society Statement on Long COVID Follow-Up.

Archive ouverte

Antoniou, Katerina M. | Vasarmidi, Eirini | Russell, Anne-Marie | Andrejak, Claire | Crestani, Bruno | Delcroix, Marion | Dinh-Xuan, Anh Tuan | Poletti, Venerino | Sverzellati, Nicola | Vitacca, Michele | Witzenrath, Martin | Tonia, Thomy | Spanevello, Antonio

Edité par CCSD ; European Respiratory Society -

International audience. Patients diagnosed with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection frequently experience symptom burden post-acute infection or post-hospitalisation. We aimed to identify optimal strategies for follow-up care that may positively impact the patient's quality of life (QoL). A European Respiratory Society (ERS) Task Force convened and prioritised eight clinical questions. A targeted search of the literature defined the timeline of "long COVID" as 1-6\hspace0.25emmonths post-infection and identified clinical evidence in the follow-up of patients. Studies meeting the inclusion criteria report an association of characteristics of acute infection with persistent symptoms, thromboembolic events in the follow-up period, and evaluations of pulmonary physiology and imaging. Importantly, this statement reviews QoL consequences, symptom burden, disability and home care follow-up. Overall, the evidence for follow-up care for patients with long COVID is limited.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion